216 related articles for article (PubMed ID: 31952781)
1. Metabolic Fitness and Plasticity in Cancer Progression.
McGuirk S; Audet-Delage Y; St-Pierre J
Trends Cancer; 2020 Jan; 6(1):49-61. PubMed ID: 31952781
[TBL] [Abstract][Full Text] [Related]
2. Cancer Plasticity: The Role of mRNA Translation.
Lee LJ; Papadopoli D; Jewer M; Del Rincon S; Topisirovic I; Lawrence MG; Postovit LM
Trends Cancer; 2021 Feb; 7(2):134-145. PubMed ID: 33067172
[TBL] [Abstract][Full Text] [Related]
3. Tumor Plasticity and Resistance to Immunotherapy.
Horn LA; Fousek K; Palena C
Trends Cancer; 2020 May; 6(5):432-441. PubMed ID: 32348738
[TBL] [Abstract][Full Text] [Related]
4. Oncogenes strike a balance between cellular growth and homeostasis.
Qiu B; Simon MC
Semin Cell Dev Biol; 2015 Jul; 43():3-10. PubMed ID: 26277544
[TBL] [Abstract][Full Text] [Related]
5. MET Inhibition Elicits PGC1α-Dependent Metabolic Reprogramming in Glioblastoma.
Zhang Y; Nguyen TTT; Shang E; Mela A; Humala N; Mahajan A; Zhao J; Shu C; Torrini C; Sanchez-Quintero MJ; Kleiner G; Bianchetti E; Westhoff MA; Quinzii CM; Karpel-Massler G; Bruce JN; Canoll P; Siegelin MD
Cancer Res; 2020 Jan; 80(1):30-43. PubMed ID: 31694905
[TBL] [Abstract][Full Text] [Related]
6. Targeting mTOR and Metabolism in Cancer: Lessons and Innovations.
Magaway C; Kim E; Jacinto E
Cells; 2019 Dec; 8(12):. PubMed ID: 31817676
[TBL] [Abstract][Full Text] [Related]
7. SR18292 exerts potent antitumor effects in multiple myeloma via inhibition of oxidative phosphorylation.
Xiang Y; Fang B; Liu Y; Yan S; Cao D; Mei H; Wang Q; Hu Y; Guo T
Life Sci; 2020 Sep; 256():117971. PubMed ID: 32553925
[TBL] [Abstract][Full Text] [Related]
8. Targeting hypoxic tumor microenvironment in pancreatic cancer.
Tao J; Yang G; Zhou W; Qiu J; Chen G; Luo W; Zhao F; You L; Zheng L; Zhang T; Zhao Y
J Hematol Oncol; 2021 Jan; 14(1):14. PubMed ID: 33436044
[TBL] [Abstract][Full Text] [Related]
9. Combined Treatment of MCF-7 Cells with AICAR and Methotrexate, Arrests Cell Cycle and Reverses Warburg Metabolism through AMP-Activated Protein Kinase (AMPK) and FOXO1.
Fodor T; Szántó M; Abdul-Rahman O; Nagy L; Dér Á; Kiss B; Bai P
PLoS One; 2016; 11(2):e0150232. PubMed ID: 26919657
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the role of AMP-activated protein kinase in metabolic reprogramming of metastatic cancer cells: targeting cellular bioenergetics and biosynthetic pathways for anti-tumor treatment.
Tyszka-Czochara M; Konieczny P; Majka M
J Physiol Pharmacol; 2018 Jun; 69(3):. PubMed ID: 30279304
[TBL] [Abstract][Full Text] [Related]
11. Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells.
Jeon MJ; Kim WG; Lim S; Choi HJ; Sim S; Kim TY; Shong YK; Kim WB
Mol Cell Endocrinol; 2016 Jan; 419():113-23. PubMed ID: 26463583
[TBL] [Abstract][Full Text] [Related]
12. Metabolic reprogramming and AMPKα1 pathway activation by caulerpin in colorectal cancer cells.
Yu H; Zhang H; Dong M; Wu Z; Shen Z; Xie Y; Kong Z; Dai X; Xu B
Int J Oncol; 2017 Jan; 50(1):161-172. PubMed ID: 27922662
[TBL] [Abstract][Full Text] [Related]
13. Epithelial to mesenchymal transition is associated with rapamycin resistance.
Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
[TBL] [Abstract][Full Text] [Related]
14. Low-folate stress reprograms cancer stem cell-like potentials and bioenergetics metabolism through activation of mTOR signaling pathway to promote in vitro invasion and in vivo tumorigenicity of lung cancers.
Chen WJ; Huang RS
J Nutr Biochem; 2018 Mar; 53():28-38. PubMed ID: 29190547
[TBL] [Abstract][Full Text] [Related]
15. Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment.
Simões RV; Serganova IS; Kruchevsky N; Leftin A; Shestov AA; Thaler HT; Sukenick G; Locasale JW; Blasberg RG; Koutcher JA; Ackerstaff E
Neoplasia; 2015 Aug; 17(8):671-84. PubMed ID: 26408259
[TBL] [Abstract][Full Text] [Related]
16. Oxystressed tumor microenvironment potentiates epithelial to mesenchymal transition and alters cellular bioenergetics towards cancer progression.
Sridaran D; Ramamoorthi G; MahaboobKhan R; Kumpati P
Tumour Biol; 2016 Oct; 37(10):13307-13322. PubMed ID: 27460079
[TBL] [Abstract][Full Text] [Related]
17. PGC1α drives a metabolic block on prostate cancer progression.
Wallace M; Metallo CM
Nat Cell Biol; 2016 May; 18(6):589-90. PubMed ID: 27230528
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-κB mediated epithelial-mesenchymal transition and stemness.
Wang J; Tian L; Khan MN; Zhang L; Chen Q; Zhao Y; Yan Q; Fu L; Liu J
Cancer Lett; 2018 Feb; 415():73-85. PubMed ID: 29199005
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory interferon activates HIF-1α-mediated epithelial-to-mesenchymal transition via PI3K/AKT/mTOR pathway.
Yeh YH; Hsiao HF; Yeh YC; Chen TW; Li TK
J Exp Clin Cancer Res; 2018 Mar; 37(1):70. PubMed ID: 29587825
[TBL] [Abstract][Full Text] [Related]
20. Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cells.
Ray U; Roy Chowdhury S; Vasudevan M; Bankar K; Roychoudhury S; Roy SS
Mol Oncol; 2017 May; 11(5):491-516. PubMed ID: 28236660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]